Inventiva (IVA) Other Non-Current Liabilities (2019 - 2025)

Inventiva's (IVA) quarterly Other Non-Current Liabilities came in at $1.4 million in Q4 2025, up 25.93% year-on-year from $1.1 million in Q4 2024, and down 99.89% quarter-over-quarter from $1.3 billion in Q2 2025.

Inventiva (IVA) Other Non-Current Liabilities (2019 - 2025) Analysis & Trends

Inventiva's Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $1.4 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 25.93% year-over-year to $1.4 million in Q4 2025; TTM through Dec 2025 was $1.4 million, a 25.93% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 25.93% from the prior year.
  • Other Non-Current Liabilities slipped to $1.4 million in Q4 2025 per IVA's latest filing, from $1.3 billion in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $1.3 billion in Q2 2025 and bottomed at $1.1 million in Q4 2024.
  • The 4-year median for Other Non-Current Liabilities is $2.1 million (2021), against an average of $214.0 million.
  • Across the five-year window, Other Non-Current Liabilities jumped 352.77% in 2021 and retreated 0.68% in 2024, its largest moves.
  • Year by year, Other Non-Current Liabilities stood at $2.9 million in 2021, then plunged by 61.21% to $1.1 million in 2023, then retreated by 0.68% to $1.1 million in 2024, then climbed by 25.93% to $1.4 million in 2025.
  • Per Business Quant, the three latest IVA Other Non-Current Liabilities figures stand at $1.4 million (Q4 2025), $1.3 billion (Q2 2025), and $1.1 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Inventiva 842.48 Mn 842.48 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.39 Mn
Jun 30, 2025 1.27 Bn
Dec 31, 2024 1.10 Mn
Dec 31, 2023 1.11 Mn
Jun 30, 2021 2.86 Mn
Mar 31, 2021 2.87 Mn
Dec 31, 2020 2.83 Mn
Jun 30, 2020 632,238.11
Dec 31, 2019 635,353.52